I'll just respond that from the perspective of any regulatory submissions we would receive for reformulated vaccine, be it for a booster or a second-generation vaccine, it would be subject to our rigorous review through the rolling review process. We would attend to that rapidly.
On April 16th, 2021. See this statement in context.